The HTA Roundtables are a platform to advance scientific methods, facilitate information sharing about the current state of HTA, its development, and its role in optimizing healthcare decisions, and to bridge the gap between technology assessors, private and public payers, regulators, and patients to improve health globally.
The ISPOR HTA Roundtables convene annually in Asia Pacific, Europe, Latin America, Middle East and Africa, and North America.
2022 HTA Roundtable - Asia Pacific
VIRTUAL | 27 September 2022
The ISPOR HTA Roundtable - Asia Pacific will be held virtually on 27 September 2022. Topics of discussion are currently TBD.
2021 HTA Roundtable - Asia Pacific
VIRTUAL | 9 November 2021
Twenty participants representing Health Technology Assessment (HTA) bodies from 18 countries in Asia Pacific attended the ISPOR HTA Roundtable - Asia Pacific. This year, the roundtable focused on two main topics: 1) The Lifecycle HTA Approach and 2) Best Practices on Contracting. Participants had the opportunity to learn from some HTA bodies in their region about the use of the lifecycle approach in their processes, from horizon scanning to scientific advice until disinvestment decisions. Attendees listened to some of the regional best practices on contracting, learned about new ways to provide access for new therapies, including the development of Managed Entry Agreements (MEA) and the implementation of tendering system as a potential solution.
2020 HTA Roundtable - Asia Pacific
VIRTUAL | 9 September 2020
On 9 September, representatives from HTA bodies in the Asia Pacific met to discuss the challenges and opportunities that have surfaced due to COVID-19; particularly the use of telehealth and the demand for rapid reviews with limited evidence. Attendees also heard presentations from representatives from South Korea, Thailand, Taiwan, India, and China on the role of HTA in universal health coverage.
Previous HTA Roundtables - Asia Pacific
- 2019 - Beijing, China
- 2018 - Tokyo, Japan
- 2017 - Taipei, Taiwan
- 2016 - Singapore
- 2015 - Astana, Kazakhstan
- 2014 - Beijing, China
- 2013 - Manila, The Philippines
- 2012 - Taipei, Taiwan
- 2010 - Phuket, Thailand
- 2008 - Seoul, South Korea
2022 HTA Roundtable - Europe
VIENNA, AUSTRIA | 6 NOVEMBER 2022
The ISPOR HTA Roundtable - Europe will be held on 6 November 2022 during ISPOR Europe 2022 in Vienna, Austria. Topics of discussion include what the future of HTA will look like and where will we be in 5 years?
2021 HTA Roundtable - Europe
VIRTUAL | 23 NOVEMBER 2021
24 attendees from 20 different European countries convened for the Virtual ISPOR HTA Roundtable-Europe. This year the Roundtable focused on two relevant topics: 1) The Role of HTA in Assessing Digital Technologies and Virtual Care and 2) HTA of Potentially Curative Therapies (ATMP). Presentations from HTA Bodies and Academicians (National Health Fund HQ, INFARMED, IQWiG, Gdańsk Medical University, AIFA) among others, discussed the needs to adapt and organize HTA activities around emerging trends.
2020 HTA Roundtable - Europe
VIRTUAL | 10 November 2020
With more than 45 attendees from over 30 countries, the ISPOR 53rd Health Technology Assessment (HTA) Roundtable – Europe convened in late 2020 to discuss balancing the increased demand for rapid reviews, and applying lessons learned to European HTA collaborations in the post-COVID environment.
Previous HTA Roundtables - Europe
- 2019 - Copenhagen, Denmark
- 2018 - Barcelona, Spain
- 2017 - Glasgow, Scotland
- 2016 - Vienna, Austria
- 2015 - Milan, Italy
- 2014 - Amsterdam The Netherlands
- 2013 - Dublin, Ireland
- 2012 - Berlin, Germany
- 2011 - Madrid, Spain
- 2010 - Prague, Czech Republic
- 2009 - Paris, France
- 2008 - Athens, Greece
- 2007 - Dublin, Ireland
2022 HTA Roundtable - Latin America
VIRTUAL | 28 JULY 2022
The ISPOR HTA Roundtable - Latin America will be held virtually on 28 July 2022. Topics of discussion will include how to include economic evaluations into HTA, the use of thresholds and budget impact, and the challenges of conducting HTA in pluralistic healthcare systems.
2021 HTA Roundtable - Latin America
VIRTUAL | 22 September 2021
More than 30 representatives from Health Technology Assessment (HTA) bodies from 18 countries in Latin America virtually met to discuss the challenges and opportunities of integrating evidence from the Real World into the HTA process. Presentations from HTA bodies in the region highlighted the challenges and the needs to develop frameworks to adapt this type of evidence into their current decision-making processes. Attendees also heard presentations from representatives from National Institute for Clinical Excellence (NICE) and CADTH (Canadian Agency for Drugs and Technologies in Health) about Best Practices on the HTA for Medical Devices.
2020 HTA Roundtable - Latin America
VIRTUAL | 15 October 2020
19 attendees from 13 countries convened for the ISPOR HTA Roundtable—Latin America. A representative from the Institute for Clinical Effectiveness and Health Policy (IECS) discussed how demand for rapid reviews of COVID treatments can be handled, followed by an open discussion. A representative from General Health Council Mexico gave a presentation on the allocation and prioritization of medical devices in the hospital setting.
Previous HTA Roundtables - Latin America
- 2019 - Bogotá, Colombia
- 2018 - Lima, Peru
- 2017 - São Paulo, Brazil
- 2016 - Bogotá, Colombia
- 2015 - Santiago, Chile
- 2014 - Santiago, Chile
- 2013 - Buenos Aires
- 2011 - Mexico City, Mexico
- 2009 - Rio de Janeiro, Brazil
2022 HTA Roundtable – Middle East and Africa
VIRTUAL | 4 OCTOBER 2022
The ISPOR HTA Roundtable - Middle East and Africa will be held virtually on 4 October 2022. The topics of discussion include the 2021 World Health Organization (WHO) survey of HTA bodies and benefits packages, the WHO guidance on financing for HTA, and the implementation of the CHEERS 2022 Statement.
2021 HTA Roundtable – Middle East and Africa
VIRTUAL | 12 OCTOBER 2021
Nearly 25 attendees from Health Technology Assessment (HTA) bodies across 14 different countries met to discuss and update the status of HTA implementation in their respective countries. Additionally, participants provided their perspectives on managed entry agreements as a potential mechanism to improve patient access. The meeting began with a Short Course training on performance-based risk sharing agreements facilitated by Professor Emeritus Adrian Towse who also moderated the follow-up Q&A and discussion.
2020 HTA Roundtable - Middle East and Africa
VIRTUAL | 8 October 2020
Eighteen attendees from 13 different countries met to discuss the status of HTA implementation in their respective countries. The roundtable featured open discussion among participants in addition to didactic presentations. Attendees received training on budget impact analysis from representatives of VI Research, followed by a presentation on the use of cost effectiveness thresholds by the National Institute for Health and Care Excellence.
Previous HTA Roundtables - Middle East and Africa
- 2019 - Abu Dhabi, UAE
- 2018 - Dubai, UAE
- 2017 - Glasgow, Scotland, UK
2023 HTA-P&T Roundtable - North America
BOSTON, MA | MAY 6, 2023
The ISPOR HTA-P&T Roundtable - North America is expected to take place during ISPOR 2023 in Boston, MA, USA on May 6, 2023.
2022 HTA-P&T Roundtable - North America
VIRTUAL | MAY 27, 2022
On May 27, 2022, more than 30 attendees representing payers, HTA bodies, and other governmental decision makers from the US, Canada, Mexico, and Australia convened for the ISPOR HTA-P&T Roundtable - North America 2022.
Two main topics were for discussion - 1) How to communicate and grade uncertainty in evidence used in HTAs; and 2) A look back on the topics discussed at the ISPOR HTA-P&T Roundtables from 2007 to present, what topics should be discussed in the future, and how can the roundtables be improved.
2021 HTA-P&T Roundtable - North America
VIRTUAL | May 12, 2021
On May 12, more than 37 attendees representing CADTH, ICER, and various US health insurers and many other organizations involved in HTA across North America convened for the ISPOR HTA Roundtable - North America 2021.
The roundtable was divided into two main topics:
Racial disparities and health equity. A panel presentation with participations from Sickle Cell Disease Association of the Midwest, the Canadian Organization for Rare Disorders, and the recent created ISPOR Special Interest Group on Health Disparities followed by open discussion.
The second topic included “The need for a lifecycle approach to HTA” featuring the presentation of Suzanne McGurn, President and CEO CADTH followed by an open discussion.
2020 HTA-P&T Roundtable - North America
VIRTUAL | June 23 & July 23, 2020
Part 1: Representatives from CADTH, ICER, various US health insurers, and many other organizations involved in HTA across North America met on June 23 to discuss the challenges and opportunities related to COVID-19. Discussion focused on the increase in expedited regulatory approvals, ultra-rapid reviews, and the impact this has on the healthcare system.
Part 2: On July 23, the ISPOR Health Technology Assessment-P&T Roundtable-North America convened to discuss digital therapeutics. Representatives from Express Scripts and the Digital Therapeutics Alliance spoke about how digital health solutions can and should be managed from a formulary standpoint and how to assess the value of digital technologies.
Previous HTA-P&T Roundtable - North America
- 2019 - New Orleans, LA
- 2018 - Baltimore, MD
- 2017 - Boston, MA
- 2016 - Washington, DC
- 2015 - Philadelphia, PA
- 2014 - Montreal, ON, Canada
- 2013 - New Orleans, LA
- 2012 - Washington, DC
- 2011 - Baltimore, MD
- 2010 - Atlanta, GA
- 2009 - Orlando, FL
- 2008 - Toronto, ON, Canada
- 2007 - Arlington, VA
Joint NICE International - ISPOR HTA Roundtable
ISPOR and NICE International, with support from the University of Melbourne and University of Sheffield, hosted a roundtable in 2021 focused on children's health related quality of life (HRQoL). The aims of the roundtable were: (a) to raise awareness of challenges when valuing children’s HRQoL and using this information in HTA; (b) to identify areas of consensus and areas of difference in approaches taken by HTA agencies; (c) to understand HTA agencies’ current perspective around the existence and development of methods guidance in this area; and (d) to find out if HTA agencies have a clear view on normative questions – such as whose preferences should inform value sets. A more in-depth summary of the roundtable discussion will be available soon.
An introductory 30 minute video was developed highlighting the challenges and current practices on measuring and valuing children’s HRQoL. The video was sent in advance to all participants to provide important contexts for the roundtable discussion. To learn more about the challenges of measuring and valuing children's HRQoL, watch the video below:
Measuring and valuing children's HRQoL
For More Information
Please contact us for information about the Health Technology Assessment Roundtables or other HTA initiatives.